500 mg Tablet
Ranolazine Tablet, Extended Release
Product Images NDC 60687-549
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 60687-549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
500 mg Ranolazine Er Tablet Blister (Blister)
Ranolazine is a medication available in the form of extended-release tablets with a strength of 500 mg. The medication is used to treat angina (chest pain) caused by heart disease. The has also captured the medication name in different forms such as Edérised-Roleasa, Exardad-Roleasa, Extoniod-Rolease, and BAORia-Gcace. The text seems to have some errors in it, but the medication description and strength are clear. The expiry date is mentioned as "odon" which is not a recognizable or interpretable format.*
500 mg Ranolazine Er Tablets Carton (Carton)
This is a description of a drug called Ranolazine. It comes in the form of extended-release tablets and has a strength of 500mg per tablet. The standard dosage needs to be determined from the packaging. The tablets should not be crushed, chewed or broken and must be stored within temperature ranges between 20°C to 25°C, with excursions permitted between 75710 to 80°C. The manufacturer is listed as NBC 1 2741125, Aanta Prarma USA inc. The NDC code specified is 60687-549-21.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
